Travel Medicine and Infectious Disease

Papers
(The H4-Index of Travel Medicine and Infectious Disease is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Immunogenicity of 4-dose Essen intramuscular regimen for rabies post-exposure prophylaxis: A multi-center cross-sectional study in China152
Omicron N501Y mutation among SARS-CoV-2 lineages: In silico analysis of potent binding to tyrosine kinase and hypothetical repurposed medicine143
Rabies post-exposure prophylaxis in the emergency department: A monocentric retrospective observational study120
Investigating the influence of probiotics in preventing Traveler's diarrhea: Meta-analysis based systematic review118
Lepromatous leprosy presenting with erythema nodosum leprosum mimicking Bechet's disease86
Monkeypox proctitis treated with doxycycline in an HIV MSM returning to Italy from France84
Prevalence of undiagnosed HIV in Venezuelan patients with suspected COVID-19 during the first wave: A complex syndemic81
Impact of COVID-19 pandemic on surveillance of Crimean-Congo haemorrhagic fever (CCHF) in Pakistan77
Blame positioning in Covid-19 response: Refugees and asylees as victims77
Awareness and perceptions of medical students and doctors regarding Tropical Medicine education and training in Europe: An international, online-based survey70
Editorial Board69
Murine typhus in returned travelers to Toronto, Canada62
The arrival of Mpox in Venezuela: Why so few cases?61
Comment on “Clinical manifestation of Rickettsia rickettsii in a familiar outbreak in Panama”58
On the potential for discontinuing atovaquone-proguanil (AP) ad-hoc post-exposure and other abbreviated AP-regimens: Pharmacology, pharmacokinetics and perspectives54
Authors' response comments on “Diagnosis of monkeypox virus – An overview”51
Efficacy of chloroquine and hydroxychloroquine in treating COVID-19 infection: A meta-review of systematic reviews and an updated meta-analysis51
Airborne infection risk of nearby passengers in a cabin environment and implications for infection control48
The Honduran diaspora and infectious diseases: An urgent need for action46
Chikungunya and arthritis: An overview46
For how long can monkeypox reach the Balkan region?43
Effect of Omicron on the prevalence of COVID-19 in international travelers at the Mexico city international airport. December 16th, 2021 to January 31st, 202243
Misleading eosinophil counts in migration-associated malaria: do not miss hidden helminthic co-infections42
Therapeutic strategies for human poxvirus infections: Monkeypox (mpox), smallpox, molluscipox, and orf38
Malaria risk perceptions and barriers for effective prophylaxis among sub-Saharan African `visiting friends and relatives´ travellers in Hamburg, Germany38
Learning from SARS and MERS: COVID-19 reinfection where do we stand?38
Evidence of autochthonous transmission of urinary schistosomiasis in Almeria (southeast Spain): An outbreak analysis37
A case of imported Plasmodium malariae infection after treated Plasmodium falciparum malaria: Possible explanations and a review of the literature36
Leukemoid-like eosinophilia in a splenectomised traveler returning from Brazil36
Is Omicron the end of pandemic or start of a new innings?36
Extensive buruli ulcer in a patient returning from Mali and Senegal36
Global spread of mpox Clade I: Implications for travel and public health35
Assessing dengue seroprevalence among people living with HIV (PLWH) in rome, Italy: Insights from the 2023 Italian autochthonous outbreak34
Types and outcomes of pharmacist-managed travel health services: A systematic review34
0.10692596435547